1. Home
  2. NUS

as 06-21-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Other Pharmaceuticals

Nasdaq

Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.

Founded: 1984 Country:
United States
United States
Employees: N/A City: PROVO
Market Cap: 671.0M IPO Year: 1996
Target Price: $20.83 AVG Volume (30 days): 895.1K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield: 1.93% Dividend Payout Frequency: Quarterly
EPS: -0.07 EPS Growth: N/A
52 Week Low/High: $11.73 - $34.32 Next Earning Date: 07-30-2024
Revenue: $1,904,975,000 Revenue Growth: -9.38%
Revenue Growth (this year): -9.05% Revenue Growth (next year): 3.24%

NUS Daily Stock ML Predictions

Stock Insider Trading Activity of Nu Skin Enterprises Inc. (NUS)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
WOODBURY EDWINA D NUS Director May 2 '24 Sell $12.02 1,693 $20,349.86 18,095 SEC Form 4
LIPMAN ANDREW D NUS Director Apr 25 '24 Sell $12.34 2,000 $24,680.00 25,225 SEC Form 4
LIPMAN ANDREW D NUS Director Mar 25 '24 Sell $12.32 2,000 $24,640.00 27,225 SEC Form 4
LIPMAN ANDREW D NUS Director Feb 26 '24 Sell $12.46 2,000 $24,920.00 29,225 SEC Form 4
LIPMAN ANDREW D NUS Director Dec 26 '23 Sell $19.39 2,000 $38,780.00 33,225 SEC Form 4
LIPMAN ANDREW D NUS Director Nov 3 '23 Sell $17.68 15,400 $272,272.00 37,225 SEC Form 4

Share on Social Networks: